Please try another search
The Alzheimer’s disease (“AD”) area is in focus once again with Pfizer Inc. (NYSE:PFE) saying that it will be dropping its plans to develop treatments for Alzheimer’s and...
Here is your Bonus Idea with links to the full Top Ten:General Electric (NYSE:GE), $GE, was a true Dog of the Dow in 2017 with its stock losing over 45% of its value. Traders and investors alike could...
Eat your heart out Christmastime. Here at Zacks, our favorite season is Earnings Season…and we get four of them each year! It’s just about time for the next one, and this more than 8-year...
Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) reported positive top-line data on pipeline candidate, M281 from a phase I single ascending dose (SAD) and multiple ascending dose (MAD) study of normal...
On Jan 5, we issued an updated research report on Ambarella, Inc. (NASDAQ:AMBA) .Notably, Ambarella, a producer of video compression and image processing semiconductors is facing decline in revenues...
The International Consumer Electronics Show, known simply as “CES,” is one of the biggest events in the world of technology. CES has grown in prominence and importance every year since it...
In what finished as a strong day for the broad technology market, shares of all four so-called “FANG” stocks—Facebook (NASDAQ:FB) , Amazon (NASDAQ:AMZN) , Netflix (NASDAQ:NFLX) ,...
For the first part of 2017 low volatility equities were outperforming their high beta counterparts. However, as tax reform talk began to look more a reality in late August, high beta stocks resumed...
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) announced positive interim data from the first dose cohort of the phase I/II study on its adeno-associated virus (“AAV”) gene therapy...
Intec Pharma's (NASDAQ:NTEC) clinical programmes to validate the utility of its unique drug delivery platform, the accordion pill (AP), are ongoing. The company announced with its Q317 report that...
The U.S. Energy Department's weekly inventory release showed a below-average decrease in natural gas supplies. Forecasts of an end to the harsh cold snap and the resultant dip in heating demand added...
We are at a turning point in history. A new technology is set to revolutionize the way we think, the way we eat and quite probably revolutionize many other aspects of our daily lives, and no. I'm not...
Emini S&P 500 topped exactly at the next target of 2746/48 we should struggle here today but shorts are obviously too risky in this trend. Bulls remain in control as we look for 2755/57 then...
Fourth quarter earnings season is officially here and Wall Street is giddy with anticipation. After what looks to be a solid holiday season, the economy also appeared to heat up by the end of the...
FTSE beat 7650 to top exactly at the next target of 7675/80. Outlook remains positive as we look for the next target of 7696/99. Trend line resistance at 7720/25 is the main challenge for bulls today...